A previous study suggested that atrophy in posterior brain areas is the signature atrophy of DLB [6, 39], although atrophy in posterior brain areas may be exacerbated by amyloid and tau co-pathology as assessed with CSF biomarkers [40]. The gene discussed is MAPT; the disease is Lewy body dementia.